Tumor-derived expression of vascular endothelial growth factor is a critical factor in tumor expansion and vascular function

Cancer Research

Volumn 59, Issue 7, 1999, Pages 1592-1598

  Grunstein, Jeremy ^a   Roberts, W Gregory ^a   Mathieu Costello, Odile ^a   Hanahan, Douglas ^b   Johnson, Randall S ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Department of Biology ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD VESSEL PERMEABILITY; CANCER GROWTH; CARCINOGENESIS; CONTROLLED STUDY; ELECTRON MICROSCOPY; FIBROSARCOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR VASCULARIZATION;

EID: 0033119833     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Risau, W. What, if anything, is an angiogenic factor? Cancer Metastasis Rev., 15: 149-151, 1996.
2. Wilting, J., and Christ, B. Embryonic angiogenesis: a review. Naturwissenschaften, 83: 153-164, 1996.
3. Hanahan, D., and Folkman, J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell, 86: 353-364, 1996.
4. Rak, J., Filmus, J., Finkenzeller, G., Grugel, S., Marmé, D., and Kerbel, R. S. Oncogenes as inducers of tumor angiogenesis. Cancer Metastasis Rev., 14: 263-277, 1995.
5. Stephan, C. C., and Brock, T. A. Vascular endothelial growth factor, a multifunctional polypeptide. Puerto Rico Health Sci. J., 15: 169-178, 1996.
6. Shweiki, D., Itin, A., Soffer, D., and Keshet, E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature (Lond.), 359: 843-845, 1992.
7. Rak, J., Mitsuhashi, Y., Bayko, L., Filmus, J., Shirasawa, S., Sasazuki, T., and Kerbel, R. S. Mutant ras oncogenes up-regulate VEGF/VPF expression: implications for induction and inhibition of tumor angiogenesis. Cancer Res., 55: 4575-4580, 1995.
8. Kolch, W., Martiny-Baron, G., Kieser, A., and Marme, D. Regulation of the expression of the VEGF/VPS and its receptors: role in tumor angiogenesis. Breast Cancer Res. Treat., 36: 139-155, 1995.
9. Takahashi, Y., Kitadai, Y., Bucana, C. D., Cleary, K. R., and Ellis, L. M. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res., 55: 3964-3968, 1995.
10. Mazure, N. M., Chen, E. Y., Yeh, P., Laderoute, K. R., and Giaccia, A. J. Oncogenic transformation and hypoxia synergistically act to modulate vascular endothelial growth factor expression. Cancer Res., 56: 3436-3440, 1996.
11. Borgström, P., Hillan, K. J., Sriramarao, P., and Ferrara, N. Complete inhibition of angiogenesis and growth of microtumors by anti-vascular endothelial growth factor neutralizing antibody: novel concepts of angiostatic therapy from intravital videomicroscopy. Cancer Res., 56: 4032-4039, 1996.
12. Kim, K. J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H. S., and Ferrara, N. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature (Lond.), 362: 841-844, 1993.
13. Fukumura, D., Xavier, R., Sugiura, T., Chen, Y., Park, E-C., Lu, N., Selig, M., Nielsen, G., Taksir, T., Jain, R., and Seed, B. Tumor induction of VEGF promoter activity in stromal cells. Cell, 94: 715-725, 1998.
14. Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O'Shea, K. S., Powell-Braxton, L., Hillan, K. J., and Moore, M. W. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature (Lond.), 380: 439-442, 1996.
15. Johnson, R., Spiegelman, B., Hanahan, D., and Wisdom, R. Cellular transformation and malignancy induced by ras require c-jun. Mol. Cell. Biol., 16: 4504-4511, 1996.
16. Gu, H., Marth, J. D., Orban, P. C., Mossmann, H., and Rajewsky, K. Deletion of a DNA polymerase β gene segment in T cells using cell type-specific gene targeting. Science (Washington DC), 265: 103-106, 1994.
17. O'Gorman, S., and Wahl, G. M. Mouse engineering. Science (Washington DC), 277: 1025, 1997.
18. Aladjem, M. I. Brody, L. L., O'Gorman, S., and Wahl, G. M. Positive selection of FLP-mediated unequal sister chromatid exchange products in mammalian cells. Mol. Cell. Biol., 17: 857-861, 1997.
19. Mortensen, R. M., Conner, D. A., Chao, S., Geisterfer-Lowrance, A. A., and Seidman, J. G. Production of homozygous mutant ES ceils with a single targeting construct, Mol Cell Biol. 12: 2391-2395, 1992.
20. Nagy, A., and Rossant, J. Production of completely ES-cell derived fetuses. In: A. Joyner (ed.), Gene Targeting: A Practical Approach. Oxford: IRL Press, 1992.
21. Lewandoski, M., and Martin, G. R. Cre-mediated chromosome loss in mice. Nat. Genet., 17: 223-225, 1997.
22. Weibel, E. R. Stereological Methods, Vol. 1. Toronto: Academic Press, 1979.
23. Roberts, W. G., and Palade, G. E. Neovasculature induced by vascular endothelial growth factor is fenestrated. Cancer Res., 57: 765-772, 1997.
24. Hanahan, D., Lane, D., Lipsich, L., Wigler, M., and Botchan, M. Characteristics of an SV40-plasmid recombinant and its movement into and out of the genome of a murine cell. Cell, 21: 127-139, 1980.
25. Meyers, E. N., Lewandoski, M., and Martin, G. R. An Fgf8 mutant allelic series generated by Cre- and Flp-mediated recombination. Nat. Genet., 18: 136-141, 1998.
26. Mombaerts, P., lacomini, J., Johnson, R. S., Herrup, K., Tonegawa, S., and Papaioannou, V. E. RAG-1-deficient mice have no mature B and T lymphocytes. Cell, 68: 869-877, 1992.
27. Lord, E. M., Harwell, L., and Koch, C. J. Detection of hypoxic cells by monoclonal antibody recognizing 2-nitroimidazole adducts. Cancer Res., 53: 5721-5726, 1993.
28. Waleh, N. S., Brody, M. D., Knapp, M. A., Mendonca, H. L., Lord, E. M., Koch, C. J., Laderoute, K. R., and Sutherland, R. M. Mapping of the vascular endothelial growth factor-producing hypoxic cells in multicellular tumor spheroids using a hypoxia-specific marker. Cancer Res., 55: 6222-6226, 1995.
29. Lee, J., Siemann, D. W., Koch, C. J., and Lord, E. M. Direct relationship between radiobiological hypoxia in tumors and monoclonal antibody detection of EF5 cellular adducts. Int. J. Cancer, 67: 372-378, 1996.
30. Siim, B. G., Menke, D. R., Done, M. J., and Brown, J. M. Tirapazamine-induced cytotoxicity and DNA damage in transplanted tumors: relationship to tumor hypoxia. Cancer Res., 57: 2922-2928, 1997.
31. Durand, R. E., and LePard, N. E. Contribution of transient blood flow to tumour hypoxia in mice. Acta Oncol., 34: 317-323, 1995.
32. Roberts, W. G., and Palade, G. E. Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J. Cell Sci., 108: 2369-2379, 1995.
33. Dvorak, A. M., Kohn, S., Morgan, E. S., Fox, P., Nagy, J. A., and Dvorak, H. F. The vesiculo-vacuolar organelle (VVO): a distinct endothelial cell structure that provides a transcellular pathway for macromolecular extravasation. J. Leukocyte Biol., 59: 100-115, 1996.
34. Evans, S. M., Jenkins, W. T., Shapiro, M., and Koch, C. J. Evaluation of the concept of "hypoxic fraction" as a descriptor of tumor oxygenation status. Adv. Exp. Med. Biol., 411: 215-225, 1997.
35. Skøyum, R., Eide, K., Berg, K., and Rofstad, E. K. Energy metabolism in human melanoma cells under hypoxic and acidic conditions in vitro. Br. J. Cancer. 76: 421-428, 1997.
36. Esser, S., Wolburg, K., Wolburg, H., Breier, G., Kurzchalia, T., and Risau, W. Vascular endothelial growth factor induces endothelial fenestrations in vitro. J.Cell Biol., 140: 947-959, 1998.
37. Holmgren, L., O'Reilly, M. S., and Folkman, J. Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat. Med., 1: 149-153, 1995.
38. Parangi, S., O'Reilly, M., Christofori, G., Holmgren, L., Grosfeld, J., Folkman, J., and Hanahan, D. Antiangiogenic therapy of transgenic mice impairs de novo tumor growth. Proc. Natl. Acad. Sci. USA, 93: 2002-2007, 1996.
39. O'Reilly, M. S., Holmgren, L., Chen, C., and Folkman, J. Angiostalin induces and sustains dormancy of human primary tumors in mice. Nat. Med., 2: 689-692, 1996.
40. Soker, S., Takashima, S., Miao, H. Q., Neufeld, G., and Klagsbrun, M. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell, 92: 735-745, 1998.